L‐Lactate–Based Improvement of Energetic Charge and Protection of Rat Liver
Bérengère Papegay, Vincent Nuyens, Véronique Kruys, Jean G. Boogaerts, Joseph Vamecq – 31 July 2019
Watching the Clock in Donation After Circulatory Death Liver Transplantation
Luis I. Ruffolo, Mark A. Levstik, Roberto Hernandez‐Alejandro – 31 July 2019
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy
Mattias Mandorfer, Karin Kozbial, Philipp Schwabl, David Chromy, Georg Semmler, Albert F. Stättermayer, Matthias Pinter, Virginia Hernández‐Gea, Monika Fritzer‐Szekeres, Petra Steindl‐Munda, Michael Trauner, Markus Peck‐Radosavljevic, Juan C. García‐Pagán, Peter Ferenci, Thomas Reiberger – 31 July 2019
Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
Tracy Davyduke, Puneeta Tandon, Mustafa Al‐Karaghouli, Juan G. Abraldes, Mang M. Ma – 29 July 2019 – Detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is essential for stratifying patients according to the risk of liver‐related morbidity. Noninvasive methods such as vibration‐controlled transient elastography (VCTE) and Fibrosis‐4 index (FIB‐4) have been recommended to identify patients for further assessment. The aim of this study was to assess the potential impact of implementing a “FIB‐4 First” strategy to triage patients entering a NAFLD assessment pathway.
Methyl‐Sensing Nuclear Receptor Liver Receptor Homolog‐1 Regulates Mitochondrial Function in Mouse Hepatocytes
Sungwoo Choi, Bingning Dong, Chih‐Chun Janet Lin, Mi Jeong Heo, Kang Ho Kim, Zhen Sun, Martin Wagner, Nagireddy Putluri, Jae Myoung Suh, Meng C. Wang, David D. Moore – 29 July 2019
Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross‐Sectional Population‐Based Study on Its Relationship From 1999 to 2016
Michael H. Le, Yee Hui Yeo, Linda Henry, Mindie H. Nguyen – 29 July 2019 – There is growing evidence that links nonalcoholic fatty liver disease (NAFLD) with impairment of renal function. As such, we aimed to demonstrate the trend of NAFLD, NAFLD with renal insufficiency (RI), disease awareness, and mortality over time. Patient data were extracted from the National Health and Nutrition Examination Survey (NHANES) 1999‐2016. A total of 14,255 adult study participants without competing liver disease or heavy drinking and with complete laboratory data were included.
Exercise Training Is Safe and Feasible in Patients Awaiting Liver Transplantation: A Pilot Randomized Controlled Trial
Matthew P. Wallen, Shelley E. Keating, Adrian Hall, Ingrid J. Hickman, Toby G. Pavey, Aidan J. Woodward, Tina L. Skinner, Graeme A. Macdonald, Jeff S. Coombes – 29 July 2019
Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?
George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou – 29 July 2019
4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
Hyung‐Don Kim, Seongyeol Park, Seongju Jeong, Yong Joon Lee, Hoyoung Lee, Chang Gon Kim, Kyung Hwan Kim, Seung‐Mo Hong, Jung‐Yun Lee, Sunghoon Kim, Hong Kwan Kim, Byung Soh Min, Jong Hee Chang, Young Seok Ju, Eui‐Cheol Shin, Gi‐Won Song, Shin Hwang, Su‐Hyung Park – 28 July 2019
Guidance for Optimal Port Placement in Pure 3‐Dimensional Laparoscopic Donor Right Hepatectomy
Jeong‐Moo Lee, Ahmed Shehta, Kyung‐Suk Suh, Suk Kyun Hong, Kyung Chul Yoon, Jae‐Hyung Cho, Nam‐Joon Yi, Kwang‐Woong Lee – 26 July 2019